{"id":"W3000291328","doi":"10.1371/journal.pone.0226724","title":"Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2)","year":2020,"lang":"en","type":"article","venue":"PLoS ONE","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"European Regional Development Fund; Instituto de Salud Carlos III","keywords":"Raltegravir; Dolutegravir; CD4-CD8 Ratio; Confidence interval; Internal medicine; CD8; Medicine; Gastroenterology; Antiretroviral therapy; Human immunodeficiency virus (HIV); Viral load; Immune system; Immunology; Lymphocyte subsets","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005565236,0.001585876,0.003363838,0.0004269203,0.0003838752,0.001016936,0.0009067022,0.001883565,0.004120378],"category_scores_gemma":[0.003711203,0.0007820119,0.002103383,0.0003474892,0.001486493,0.00114727,0.0006803439,0.002679976,0.0008080328],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006521147,"about_ca_system_score_gemma":0.001504007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004119565,"about_ca_topic_score_gemma":0.0007880369,"domain_scores_codex":[0.9973565,0.001771328,0.0001679567,0.000346093,0.0001558855,0.0002021748],"domain_scores_gemma":[0.9967136,0.0009591389,0.0009443927,0.0004689039,0.000235117,0.0006787988],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9869499,0.006729103,0.0002846046,0.0001178071,0.0002371298,0.00000963978,0.0000250029,0.0001408074,0.002129199,0.00002459957,0.00009133139,0.003260928],"study_design_scores_gemma":[0.7699435,0.226484,0.001764485,0.00001223903,0.0002226734,0.00001898089,0.000013854,0.00040402,0.0008044914,0.00008873554,0.0002295005,0.0000135084],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949164,0.0006658306,0.000444705,0.0001468416,0.0002219238,0.002633793,0.0004418654,0.00006499816,0.0004636143],"genre_scores_gemma":[0.987894,0.000486136,0.002785099,0.0003917509,0.000333389,0.005019315,0.0007581198,0.00002008705,0.002312134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005565236,"threshold_uncertainty_score":0.02943218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2240413115892959,"score_gpt":0.362007524513807,"score_spread":0.1379662129245111,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}